8-K/A

OXIGENE 8-K/A

Company: Oncotelic Therapeutics, Inc.
Filed: August 8, 2003
Period of Report: August 8, 2003
Accession Number: 0001157523-03-003840

View Document ↗ View on SEC.gov ↗